About 5 Trademarks found that are owned by Chemo Iberica Sa

Color is not claimed as a feature of the mark.

[ Sales promotion for third parties, business management assistance; consulting on business management and marketing studies; presentation of goods on communication media, for retail purposes; business administration of product licenses and services for others; ] organization of exhibitions, trade fairs or congresses for business or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products *, but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *

In the Statement, Page 1, lines 12 and 13, "gastro-intestinal diseases, genitourinary diseases" should be deleted, and, "gastrointestinal diseases, genitourinary disorders" should be inserted, and, In the Statement, Page 1, line 15, "use in the" should be deleted, and, In the Statement,Page 1, lines 16-18, "neurological diseases and disorders, psychiatric diseases, diseases of the central nervous system," should be deleted, and, In the Statement, Page 1, line 19, "diseases of the circulatory system," should be deleted, and, "circulatory diseases," should be inserted, and, In the Statement, Page 1, line 20, "headaches, migraines," should be deleted, and, In the Statement, Page 1, line 21, "in liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, "preparations" should be deleted, and, "products" should be inserted and In the Statement, Page 1, lines 25 and 28, "the" should be deleted, and, In the Statement, Page 1, line 27, " immunological diseases" should be deleted, and, "immunological disorders" should be inserted, and, In the Statement, Page 1, line 30, " headaches, migraines" should be deleted, and, In the Statement, Page 1, line 31, "liver treatment" should be deleted, and, "treatment of the liver" should be inserted, and, In the Statement, Page 1, line 34, after USE, "; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 2,"ophthalmological" should be deleted, and, "ophthalmic" should be inserted, and, In the Statement, Page 2, line 5, "use" should be deleted, and, "purposes" should be inserted, and, In the Statement, Page 2, line, 8, "consulting" should be deleted, and, "consultancy" should be inserted, and, In the Statement, Page 2, line 9, "any kind of" should be deleted, and, "all" should be inserted, and, In the Statement, Page 2, lines 11 and 12, "trade fairs or congresses for business" should be deleted, and, "trade fairs and conventions for commercial" should be inserted, and, In the Statement, Page 2, line 14, after PRODUCTS, "; but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, line 16, after SERVICES, "; all the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted.

The mark consists of the word "Exeltis" in dark blue, in rounded font and with the first letter capitalized, under which there is the phrase "Rethinking healthcare" in light blue, also in rounded font but smaller in size lower and with only the first letter of the first word capitalized. To the left of these words is a logo in dark blue and light blue consisting of seven leaves of diminishing size linked at their bases and opening in array with tips pointing outwards.

The mark consists of a helix design in the colors green, light green, light blue, blue and dark blue with the stylized wording "CHEMO" below the design in gray.

In the Statement, class 1 has been corrected per the Restriction, and per the fnote dated March 22, 2021.

The mark consists of the wording "CHEMO", with each letter surrounded by a polygon.

"CHEMO"

Technical consultation and research in the field of the chemical and pharmaceutical industry